Net clinical benefit of anticoagulant therapy from a neurologist's perspective: A review

In this article the concept of "net clinical benefit" (NCB) is considered in context stroke, role direct oral anticoagulants secondary prevention cardioembolic stroke and NCB from their prescription. Practical aspects evaluation neurologist's point view are presented, taking into account such factors as duration severity, features neurological deficit (severity residual limitations, dysphagia, motor disorders risk falls), neuroimaging characteristics (focal size hemorrhagic transformation) concomitant diseases (epilepsy dementia). all these situations, use has a significant benefit, which justifies inadmissibility refusal to prescribe them.